Literature DB >> 9874193

The deletion of the C-terminal tail and addition of an endoplasmic reticulum targeting signal to Alzheimer's amyloid precursor protein change its localization, secretion, and intracellular proteolysis.

Z Kouchi1, T Kinouchi, H Sorimachi, S Ishiura, K Suzuki.   

Abstract

The metabolic pathway of Alzheimer's amyloid precursor protein (APP) involves restricted intracellular proteolysis by secretases, which leads to the secretion of the N-terminal soluble APP (sAPP) and the generation of a cell-associated C-terminal fragment. The precise cellular sites at which these processes occur remain unknown. In this report, we describe the route of APP sorting and the processing site using novel systems with and without sorting signals on the APP molecule. One system involves the replacement of the C-terminal ten amino acids of APP with Adenoviral E19 protein containing an endoplasmic reticulum (ER) retrieval signal (APPE19); the other involves deleting the last ten amino acids corresponding to the replaced site (APPdeltaC10). APPE19 localized mainly within the cis/medial Golgi compartment and exclusively suppresses the secretion of APP. In contrast, deletion of the C-terminal tail promotes sAPP secretion by a constitutive secretion pathway. Metabolic labeling followed by immunoprecipitation with anti-APP antibody revealed that APPE19 is rapidly degraded within 30 min and that the subsequent intracellular turnover rate is decreased with 40% of the protein retained within the cells even after a chase period a 3 h. In contrast, APPdeltaC10 is rapidly eliminated from the intracellular compartments and secreted into the culture medium. The surface internalization and recycling processes of this protein are relatively impaired compared with wild-type APP. The ratios of the levels of production to secretion of sAPP alpha, the N-terminal, soluble APP fragment released by alpha-secretase, are proportional to the secretion efficiencies among APP species, suggesting the localization of alpha-secretase within a compartment late in the constitutive secretion pathway. These secretion mutants which utilize ER targeting signals are useful tools for analyzing the location of secretases and the intracellular degradation system within a constitutive secretion pathway such as ER quality control.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874193     DOI: 10.1046/j.1432-1327.1998.2580291.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Metabolism of amyloid precursor protein in COS cells transfected with a beta-secretase candidate.

Authors:  H Koike; Z Kouchi; T Kinouchi; T Maeda; H Sorimachi; T C Saido; K Maruyama; A Okuyama; K Suzuki; S Ishiura
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase.

Authors:  P Nash; M Barry; B T Seet; K Veugelers; S Hota; J Heger; C Hodgkinson; K Graham; R J Jackson; G McFadden
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

3.  Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.

Authors:  Marcus O W Grimm; Sven Grösgen; Tatjana L Rothhaar; Verena K Burg; Benjamin Hundsdörfer; Viola J Haupenthal; Petra Friess; Ulrike Müller; Klaus Fassbender; Matthias Riemenschneider; Heike S Grimm; Tobias Hartmann
Journal:  Int J Alzheimers Dis       Date:  2011-05-18

4.  Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.

Authors:  Marcus O W Grimm; Eva G Zinser; Sven Grösgen; Benjamin Hundsdörfer; Tatjana L Rothhaar; Verena K Burg; Lars Kaestner; Thomas A Bayer; Peter Lipp; Ulrike Müller; Heike S Grimm; Tobias Hartmann
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion.

Authors:  Hitomi Komura; Shota Kakio; Tomoya Sasahara; Yoshie Arai; Naomi Takino; Michio Sato; Kaori Satomura; Takayuki Ohnishi; Yo-Ichi Nabeshima; Shin-Ichi Muramatsu; Isao Kii; Minako Hoshi
Journal:  iScience       Date:  2019-02-28

6.  Multiplex assay for live-cell monitoring of cellular fates of amyloid-β precursor protein (APP).

Authors:  Maria Merezhko; Pranuthi Muggalla; Niko-Petteri Nykänen; Xu Yan; Prasanna Sakha; Henri J Huttunen
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

7.  ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.

Authors:  Florent Letronne; Geoffroy Laumet; Anne-Marie Ayral; Julien Chapuis; Florie Demiautte; Mathias Laga; Michel E Vandenberghe; Nicolas Malmanche; Florence Leroux; Fanny Eysert; Yoann Sottejeau; Linda Chami; Amandine Flaig; Charlotte Bauer; Pierre Dourlen; Marie Lesaffre; Charlotte Delay; Ludovic Huot; Julie Dumont; Elisabeth Werkmeister; Franck Lafont; Tiago Mendes; Franck Hansmannel; Bart Dermaut; Benoit Deprez; Anne-Sophie Hérard; Marc Dhenain; Nicolas Souedet; Florence Pasquier; David Tulasne; Claudine Berr; Jean-Jacques Hauw; Yves Lemoine; Philippe Amouyel; David Mann; Rebecca Déprez; Frédéric Checler; David Hot; Thierry Delzescaux; Kris Gevaert; Jean-Charles Lambert
Journal:  EBioMedicine       Date:  2016-06-02       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.